Your browser doesn't support javascript.
loading
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo; Pietrasanta, Daniela; Loseto, Giacomo; Consoli, Ugo; Scortechini, Ilaria; Rossi, Francesca Maria; Zucchetto, Antonella; Al-Janazreh, Hamdi; Vigna, Ernesto; Martino, Enrica Antonia; Mendicino, Francesco; Cassin, Ramona; D'Arrigo, Graziella; Galimberti, Sara; Rago, Angela; Angeletti, Ilaria; Biagi, Annalisa; Del Giudice, Ilaria; Bomben, Riccardo; Neri, Antonino; Fronza, Gilberto; Monti, Paola; Menichini, Paola; Cutrona, Giovanna; Jaksic, Ozren; Rossi, Davide; Di Raimondo, Francesco; Cuneo, Antonio; Gaidano, Gianluca; Polliack, Aaron; Trentin, Livio; Foà, Robin; Ferrarini, Manlio; Gattei, Valter; Gentile, Massimo.
Afiliação
  • Morabito F; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.
  • Tripepi G; Hematology and Bone Marrow Transplant Unit, Hemato-Oncology Department, Augusta Victoria Hospital, East Jerusalem, Israel.
  • Del Poeta G; CNR-IFC, Research Unit of Reggio Calabria, Reggio Calabria, Italy.
  • Mauro FR; Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
  • Reda G; Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • Sportoletti P; Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
  • Laurenti L; Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Coscia M; Fondazione Universitaria Policlinico A Gemelli di Roma, Roma, Italy.
  • Herishanu Y; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
  • Bossio S; Sourasky Medical Center, Institute of Hematology and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Varettoni M; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.
  • Murru R; Division of Haematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Chiarenza A; Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, Cagliari, Italy.
  • Visentin A; Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy.
  • Condoluci A; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy.
  • Moia R; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Pietrasanta D; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Loseto G; Division of Hematology, Azienda Ospedaliera SS Arrigo e Biagio e Cesare Arrigo, Alessandria, Italy.
  • Consoli U; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
  • Scortechini I; Hematology Department, G. Garibaldi Hospital, Catania, Italy.
  • Rossi FM; Clinica di Ematologia Ospedali Riuniti, Ancona, Italy.
  • Zucchetto A; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Al-Janazreh H; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Vigna E; Hematology and Bone Marrow Transplant Unit, Hemato-Oncology Department, Augusta Victoria Hospital, East Jerusalem, Israel.
  • Martino EA; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.
  • Mendicino F; Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Cassin R; Hematology Unit AO of Cosenza, Cosenza, Italy.
  • D'Arrigo G; Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Galimberti S; Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
  • Rago A; CNR-IFC, Research Unit of Reggio Calabria, Reggio Calabria, Italy.
  • Angeletti I; Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Biagi A; UOSD Ematologia ASL Roma 1, Roma, Italy.
  • Del Giudice I; Reparto di Oncoematologia Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.
  • Bomben R; Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
  • Neri A; Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • Fronza G; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Monti P; Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
  • Menichini P; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Cutrona G; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Jaksic O; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Rossi D; Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Di Raimondo F; Department of Hematology, Dubrava Univerisity Hospital, Zagreb, Croatia.
  • Cuneo A; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Gaidano G; Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy.
  • Polliack A; Hematology Section, Department of Medical Sciences, University of Ferrara, Cona, Italy.
  • Trentin L; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Foà R; Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Ferrarini M; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy.
  • Gattei V; Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • Gentile M; Department of Experimental Medicine, University of Genoa, Genoa, Italy.
Eur J Haematol ; 106(4): 493-499, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33378569
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article